Single-center prospective study of Axicabtagene ciloleucel and tisagenlecleucel in lymphoma patients
Latest Information Update: 13 Jan 2023
At a glance
- Drugs Axicabtagene ciloleucel (Primary) ; Tisagenlecleucel (Primary)
- Indications Diffuse large B cell lymphoma; Follicular lymphoma; Lymphoma
- Focus Therapeutic Use
- 13 Jan 2023 New trial record
- 13 Dec 2022 Results presented at the 64th American Society of Hematology Annual Meeting and Exposition